Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours

Cancer Immunology, Immunotherapy

Volumn 63, Issue 11, 2014, Pages 1129-1140

  Swierzko, Anna St ^a   Szala, Agnieszka ^a   Sawicki, Sambor ^b   Szemraj, Janusz ^c   Sniadecki, Marcin ^b   Sokolowska, Anna ^a   Kaluzynski, Andrzej ^d   Wydra, Dariusz ^b   Cedzynski, Maciej ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

^d POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Benign ovarian tumours; Complement; Mannose Binding Lectin (MBL); MASP; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN; COMPLEMENT; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN; MASP2 PROTEIN, HUMAN; MBL2 PROTEIN, HUMAN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HOMOZYGOTE; HUMAN; METABOLISM; MIDDLE AGED; OVARY TUMOR; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; COMPLEMENT SYSTEM PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HOMOZYGOTE; HUMANS; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84924921801     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-014-1579-y     Document Type: Article

References (45)

1. Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SR, Koutoulaki A, Gerard C, Coukos G, Lambris JD (2008) Modulation of the antitumor immune response by complement. Nat Immunol 9:1225–1235
2. Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T (1999) Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding protein-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci 96:371–375
3. Swierzko AS, Kilpatrick DC, Cedzynski M (2013) Mannan-binding lectin in malignancy. Mol Immunol 55:16–21
4. MacDonald SL, Downing I, Atkinson AP, Gallagher RC, Turner ML, Kilpatrick DC (2010) Dendritic cells previously exposed to mannan-binding lectin enhance cytokine production in allogeneic mononuclear cell cultures. Hum Immunol 71:1077–1083
5. Wang Y, Chen AD, Lei YM, Shan GQ, Zhang LY, Lu X, Chen ZL (2013) Mannose-binding lectin inhibits monocyte proliferation trough Transforming Growth Factor-β1 and p38 signaling pathways. PLoS ONE 8:e72505
6. Hummelshoj T, Munthe-Fog L, Madsen HO, Sim RB, Garred P (2008) Comparative study of the human ficolins reveals unique features of ficolin-3 (Hakata antigen). Mol Immunol 45:1623–1632
7. Swierzko AS, Florczak K, Cedzynski M, Szemraj J, Wydra D, Bak-Romaniszyn L, Emerich J, Sulowska Z (2007) Mannan-binding lectin (MBL) in women with tumours of the reproductive system. Cancer Immunol Immunother 56:959–971
8. Arai T, Tabona P, Summerfield JA (1993) Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock. Q J Med 86:575–582
9. Sorensen CM, Hansen TK, Steffensen R, Jensenius JC, Thiel S (2006) Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol 145:173–182
10. Stover C, Endo Y, Takahashi M, Lynch NJ, Constantinescu C, Vorup-Jensen T, Thiel S, Friedl H, Hakeln T, Hall R, Gregory S, Fujita T, Schwaeble W (2001) The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3. Genes Immun 2:119–127
11. Thiel S, Steffensen R, Christensen IJ, Ip WK, Lau YL, Reason IJ, Eiberg H, Gadjeva M, Ruseva M, Jensenius JC (2007) Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun 8:154–163
12. Degn SE, Jensen L, Hansen AG, Duman D, Tekin M, Jensenius JC, Thiel S (2012) Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol 189:3957–3969
13. Heja D, Kocsis A, Dobo J, Szilagyi K, Szasz R, Zavodszky P, Pal G, Gal P (2012) Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA 109:10498–10503
14. Megyeri M, Harmat V, Major B, Vegh A, Balczer J, Heja D, Szilagyi K, Datz D, Pal G, Zavodszky P, Gal P, Dobo J (2013) Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of complement lectin pathway. J Biol Chem 288:8922–8934
15. Yongqing T, Dretin N, Duncan RD, Wijeyewickrema LC, Pike RN (2012) Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions ? Biochim Biophys Acta 1824:253–262
16. Matsushita M, Endo Y, Fujita T (2013) Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication. Arch Immunol Ther Exp 61:273–283
17. Dobo J, Major B, Kekesi KA, Szabo I, Megyeri M, Hajela K, Juhasz G, Zavodszky P, Gal P (2011) Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS ONE 6:e20036
18. Nonaka M, Kimura A (2006) Genomic view of the evolution of the complement system. Immunogenetics 58:701–713
19. Lynch NJ, Khan SU, Stover CM, Sandrini SM, Marston D, Presanis JS, Schwaeble WJ (2005) Composition of the lectin pathway of complement in Gallus gallus: absence of mannan-binding lectin-associated serine protease-1 in birds. J Immunol 174:4998–5006
20. Seyfarth J, Garred P, Madsen HO (2006) Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol 43:962–971
21. Endo Y, Takahashi M, Kuraya M, Matsushita M, Stover CM, Schwaeble WJ, Fujita T (2002) Functional characterization of human mannose-binding lectin-associated serine protease (MASP)-1/3 and MASP-2 promoters, and comparison with the C1 s promoter. Int Immunol 14:1193–1201
22. Szala A, Sawicki S, ASt Swierzko, Szemraj J, Sniadecki M, Michalski M, Kaluzynski A, Lukasiewicz J, Maciejewska A, Wydra D, Kilpatrick DC, Cedzynski M (2013) Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours. Cancer Immunol Immunother 62:1411–1419
23. Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K, Kilpatrick DC (2004) Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 136:304–311
24. Swierzko ASt, Cedzynski M, Domzalska-Popadiuk I, MacDonald SL, Borkowska-Klos M, Atkinson APM, Szala A, Jopek A, Jensenius JC, Kawakami M, Szczapa J, Matsushita M, Szemraj J, Turner ML, Kilpatrick DC (2009) Mannan-binding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations. Mol Immunol 46:1696–1701
25. Presanis J, Hajela K, Ambrus G, Gal P, Sim RB (2004) Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol Immunol 40:921–929
26. Kilpatrick DC (2007) Clinical significance of mannan-binding lectin and L-ficolin. In: Kilpatrick D (ed) Collagen-related lectins in innate immunity. Research Signpost, Trivandrum, pp 57–84
27. Heitzeneder S, Seidel M, Forster-Waldl E, Heitiger A (2012) Mannan-binding lectin deficiency—good news, bad news, doesn’t matter? Clin Immunol 143:22–38
28. Bak-Romaniszyn L, Szala A, Sokolowska A, Mierzwa G, Czerwionka-Szaflarska M, Swierzko ASt, Zeman K, Cedzynski M (2011) Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease. Scand J Gastroenterol 46:1275–1278
29. Li YL, Ye F, Hu Y, Lu WG, Xie X (2009) Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction. Anal Biochem 394:110–116
30. Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41–49
31. Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact tests of Hardy–Weinberg equilibrium. Am J Hum Genet 76:883–887
32. Maccio A, Madeddu C (2012) Inflammation and ovarian cancer. Cytokine 58:133–147
33. Nevadunsky NS, Korneeva I, Caputo T, Witkin SS (2012) Mannose-binding lectin codon 54 genetic polymorphism and vaginal protein levels in women with gynecologic malignancies. Eur J Obstet Gynecol Reprod Biol 163:216–218
34. Baccarelli A, Hou L, Chen J, Lissowska J, El-Omra EM, Grillo P, Giacomini SM, Yaeger M, Bernig T, Zatonski W, Fraumeni JF Jr, Chanock SJ, Chow WH (2006) Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 119:1970–1975
35. Scudiero O, Nardone G, Omodei D, Tatangelo F, Vitale DF, Dalvatore F, Castaldo G (2006) A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clin Chem 52:1625–1626
36. Eurich D, Boas-Knoop S, Morawietz L, Neuhaus R, Somasundaram R, Ruehl M, Neumann UP, Neuhaus P, Bahra M, Seehofer D (2011) Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma. Liver Int 31:1006–1012
37. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, McClary AC, Bowman ED, Goodman JE, Bernig T, Chanock SJ, Harris CC (2012) 3′-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Res 72:1467–1477
38. Michaud DS, Siddig A, Cox DG, Backes DM, Calboli FC, Sughrue ME, Gaziano JM, Ma J, Stampfer M, Tworoger SS, Hunter DJ, Camargo CA Jr, Parsa AT (2013) Mannose-binding lectin 2 gene and risk of adult glioma. PLoS ONE 8:e61117
39. Schmiegelow K, Garred P, Lausen B, Andreassen B, Petersen BL, Madsen HO (2002) Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. Blood 100:3757–3760
40. Ytting H, Christensen IJ, Steffensen R, Alsner J, Thiel S, Jensenius JC, Hansen U, Nielsen HJ (2011) Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Scand J Immunol 73:122–127
41. Shi Y, Liu G, Zhang H, Yu F, Xiang X, Lu Y, Dong X, Li X (2013) Expressions and clinical significances of mannose-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) in patients with thyroid neoplasm. Chin Ger J Clin Oncol 12:106–108
42. Ytting H, Christensen IJ, Thiel S, Jensenius JC, Nielsen HJ (2005) Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality. Clin Cancer Res 11:1441–1446
43. Ytting H, Christensen IJ, Thiel S, Jensenius JC, Nielsen HJ (2008) Pre- and postoperative levels in serum mannan-binding lectin-associated serine protease-2—a prognostic marker in colorectal cancer. Hum Immunol 69:414–420
44. Fisch UP, Zehnder A, Hirt A, Niggli FK, Simon A, Ozsahin H, Schlapbach LJ, Ammann RA (2011) Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer. Swiss Med Wkly 141:w13191
45. Lu Y, Sun G, Liu G, Shi Y, Han Y, Yu F, Xiang X, Li W, Xiao H, Liu X, Sha L (2013) Clinical significance of mannose-binding lectin expression in thyroid carcinoma tissues. Pathol Oncol Res 19:259–266